Siolta Therapeutics Revenue and Competitors

Location

$47M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Siolta Therapeutics's estimated annual revenue is currently $2.8M per year.(i)
  • Siolta Therapeutics's estimated revenue per employee is $155,000
  • Siolta Therapeutics's total funding is $47M.

Employee Data

  • Siolta Therapeutics has 18 Employees.(i)
  • Siolta Therapeutics grew their employee count by -10% last year.

Siolta Therapeutics's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
VP Quality and CMCReveal Email/Phone
3
Director MicrobiologyReveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
5
Director Clinical OperationsReveal Email/Phone
6
Chief Medical OfficerReveal Email/Phone
7
Senior ScientistReveal Email/Phone
8
ScientistReveal Email/Phone
9
ScientistReveal Email/Phone
10
Research associateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Siolta Therapeutics?

Siolta Therapeutics is an early stage, venture-backed biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases. Located in the historic Dogpatch area of San Francisco, we are a part of the innovative incubator program offered by QB3@953.

keywords:N/A

$47M

Total Funding

18

Number of Employees

$2.8M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Siolta Therapeutics News

2022-04-06 - The live biotherapeutic products and microbiome manufacturing ...

70 microbiome therapeutics developers are likely to forge ... Nikole Kimes (Founder and Chief Executive Officer, Siolta Therapeutics)...

2022-02-22 - Siolta Therapeutics Awarded NIH Grant

Siolta Therapeutics is a clinical-stage biopharmaceutical company developing novel microbiome-based targeted therapeutics for the prevention...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M186%$38.3M
#2
$0.6M18-5%$88.5M
#3
$1.7M180%N/A
#4
$1.4M18-44%$37.8M
#5
$1.6M18-10%N/A